Arch Therapeutics Provides Update on Reimbursement Strategy

Initial A4100 code being deployed and application for specific HCPCS product code to be submitted in the second calendar quarter...

Related Keywords

United States ,Canada ,Dan Yrigoyen ,Michael Abrams ,Arch Therapeutics Inc ,Pilot Program The ,Centers For Medicare ,Securities Exchange ,Medicaid Services ,Lovell Government Services ,Pilot Program ,Advanced Wound System ,Centurion Therapeutics ,New Temporary Code ,Synthetic Skin ,Effective April ,Multi Site Clinical ,Arch Therapeutics ,Vice President ,Topical Hemostat ,Securities Act ,Securities Exchange Act ,Other Otc Arth ,Nc ,C5 Advanced Wound System ,Mc5 ,Wound Care ,Acute Wounds ,